Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The day that never happened: A case of transient global amnesia.

The American journal of medicine·2026
Same author

Case reports in clinical medicine: why it matters and how to do it.

Internal medicine journal·2026
Same author

Evolving practice of general internal medicine in the current medical landscape.

Internal medicine journal·2026
Same author

The paradox of superstitions in scientific, evidence-based medical practice.

Postgraduate medical journal·2026
Same author

Elderly-onset seronegative inflammatory arthritis: a narrative review and practical approach.

The American journal of medicine·2026
Same author

Workplace-based assessments: common pitfalls and mitigating strategies.

Internal medicine journal·2026

Related Experiment Videos

Statin-Related Myotoxicity: A Narrative Review and Practical Approach for General Internists.

Isaac Ks Ng1,2, Kevin Sh Teo2,3, Hui Yang2

  • 1Division of Rheumatology & Allergy, Department of Medicine, National University Hospital, Singapore, Singapore.

Journal of General Internal Medicine
|June 24, 2026
PubMed
Summary

Statins are widely used for cardiovascular health but can cause muscle symptoms in 5-10% of patients. This review offers internists an approach to managing statin-associated myotoxicity, from mild effects to severe myopathies.

Keywords:
statin-associated muscle symptomsstatin-induced myotoxicitystatin-induced necrotising autoimmune myopathy

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Cardiology
  • Neurology

Background:

  • Statins are primary agents for hyperlipidemia, cerebrovascular, and cardiovascular disease.
  • They offer significant cardiovascular benefits, pleiotropic effects, and a good safety profile.
  • Widespread use necessitates awareness of potential side effects.

Purpose of the Study:

  • To provide a practical, up-to-date overview of statin-associated myotoxicity.
  • To guide general internists in managing patients experiencing these adverse effects.
  • To differentiate between common and severe forms of statin myopathy.

Main Methods:

  • Narrative review of existing literature.
  • Synthesis of clinical information on statin-associated myotoxicity.
  • Focus on practical management strategies for internists.

Main Results:

  • Statin-associated muscular symptoms affect 5-10% of patients.
  • Most cases are benign and manageable through dose adjustment or switching statins.
  • Rare instances involve severe myopathies, rhabdomyolysis, and autoimmune necrotising myositis.

Conclusions:

  • General internists must be vigilant for statin-associated myotoxicity.
  • A structured approach is needed to manage the spectrum of muscle-related side effects.
  • Early recognition and appropriate management are crucial for patient safety.